Advertisement
Advertisement
U.S. markets open in 9 hours 8 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Capricor Therapeutics, Inc. (CAPR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.79+0.03 (+0.52%)
At close: 04:00PM EDT
5.75 -0.04 (-0.69%)
After hours: 05:16PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • S
    Sweet
    only one in green today
  • P
    Peter
    Still looking promising and great for everyone if the treatments can prevail! Happy to stay long as is will come good eventually (I hope).
    Bullish
  • S
    Sweet
    what is going on with this one?
  • P
    Peter
    CAPR looking strong
  • g
    gayle siebern
    then CAP-1002 looks like the “best new drug” for treating DMD, especially in non-ambulatory patients. Furthermore, the data seems to point towards significant label expansions for the program.
  • S
    Sweet
    not much going on to spark the hike
  • g
    gayle siebern
    Market Cap: Micro Cap
    $147.78M
    Shares Outstanding
    24.35M
    Shares held by Institutions
    10.17%
    Enterprise Value
    $94.14M
    9/8/22
  • d
    dc
    lots of spam, and its rising, me thinks something is up, breaking out here
  • d
    dc
    chart is looking very good here for move higher
  • D
    DavidC
    Very excited that Capricor will present to FDA for AA. The wait will be over and these kids can start enjoying longer lives. Thank you for your perseverance.
    Bullish
  • P
    Peter
    Anyone see 7 in the not too far distance
  • w
    william
    I hope so. With a little bit of hype I’ve seen this thing move a couple dollars in a day easily
  • C
    Chuck
    On our way to $7.00
  • S
    Smarty
    The reason it is falling down may be the video conferencing yesterday. Anytime they open their mouth, stock falls. That is the pattern I have been seeing all the time. If they keep mum, stock fares better. Another reason I guess is that we have to wait till late 2024 to see a product, if everything including their talking goes well as per FDA. Not many people want to tie up their money that long. They may sell and go somewhere else.
  • E
    Erik
    SRPT announces filing BLA results in $700 million gain in market cap ($8 × 87.5 mil shares). Time for Linda to do the same for CAP-1002.
  • N
    Nick
    Phase 3 will fail!
    Plenty of tricks the FDA and their so called independent subsidiaries can do to make the trial have mixed results. They could put sicker patients in the treatment arm like they did in Phase 2. They put someone in the worst possible condition (doesn't even respond to steroids) in the treatment arm. They can skew the patients a little older in the treatment arm. They can skew patients with more medical conditions (diabetes, hyptertension, etc into the treatment arm. Or they can place patients in optimal age and health into the control arm. Either way they are not going to pay JAPAN and they are not going to approve a therapeutic that works because it would raise the bar for everyone. I've lost money before let my experience be your guide.
    Bearish
Advertisement
Advertisement